Literature DB >> 6318661

Interaction of cefotaxime and aminoglycosides against enterococci in vitro.

A M Elliott, G H Karam, C G Cobbs.   

Abstract

The antibacterial activities of cefotaxime, gentamicin, tobramycin, and amikacin as well as the combinations of cefotaxime and aminoglycosides were tested against 50 strains of enterococci. Synergy studies were performed by the time-kill method, and with this technique the combination of cefotaxime plus gentamicin appeared to be more active than the combination of cefotaxime plus tobramycin or cefotaxime plus amikacin. Results of this in vitro study suggest cefotaxime and gentamicin may provide some activity against enterococci, although not sufficient to substitute for proven therapy such as penicillin-ampicillin and gentamicin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318661      PMCID: PMC185394          DOI: 10.1128/AAC.24.6.847

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Cephalosporin-aminoglycoside synergism in experimental enterococcal endocarditis.

Authors:  A J Weinstein; A L Lentnek
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

Review 2.  The new beta-lactamase-stable cephalosporins.

Authors:  H C Neu
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

3.  Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

Authors:  V L Yu
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

4.  Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

Authors:  H O Hallander; K Dornbusch; L Gezelius; K Jacobson; I Karlsson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

5.  Moxalactam in the therapy of serious infections.

Authors:  R L Marier; S Faro; C V Sanders; W Williams; F Derks; A Janney; K Aldridge
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

  5 in total
  1 in total

Review 1.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.